Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Int J Eat Disord. 2022 Apr 2;55(6):763–775. doi: 10.1002/eat.23711

Table 3.

Prevalence of eating disorder diagnostic and risk categories by gender.

Total (N = 818) Males (n = 348) Females (n = 470) Significance
n (%) n (%) n (%) χ2(df); p
Eating disorder diagnostic and risk categories
Low risk 178(21.8) 92 (26.3)a 86 (18.4)b 8.72 (2, 817); <0.05
High risk 161 (19.7) 59 (17.1) 102 (21.7)
EDs 479 (58.5) 197 (56.6) 282 (59.9)
 AN 7 (0.8) 0 7 (1.4)
 BN 11 (1.4) 5 (1.5) 6 (1.3)
 BED 1 (0.1) 0 1 (0.2)
 OSFED-BN 116 (14.1) 42 (12.2) 74 (15.6)
 OSFED- BED 2 (0.3) 0 2 (0.5)
 OSFED-PD 1 (0.1) 0 1 (0.2)
 OSFED-other 302 (36.9) 132 (37.8) 170 (36.3)
 ARFID 39 (4.8) 18 (5.2) 21 (4.6)

Note. AN = Anorexia nervosa; BN = Bulimia nervosa; BED = Binge eating disorder; OSFED-BN = Other specified feeding or eating disorder bulimia nervosa (of low frequency and/or limited duration); OSFED-BED = Other specified feeding or eating disorder binge eating disorder (of low frequency and/or limited duration); OSFED-PD = Other specified feeding and eating disorder - purging disorder; OSFED - other = Other feeding or eating disorder - other; ARFID = Avoidant/restrictive food intake disorder. ED= All possible DSM-5 clinical/OSFED diagnosis groups.

Raked weights based on those assigned an ED category were applied to the analysis. Gender differences for ED diagnostic and risk categories was tested using a chi-square test. As some cells had 5 or less observations, we collapsed across ED diagnostic categories. The chi-square test is calculated on a 3 (low risk, high risk, ED) X 2 (men, women) table. Groups with different superscripts are significantly different from each other (p < .05).